Enveric Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Enveric Biosciences has a total shareholder equity of $4.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.8M and $839.2K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.11m |
| Equity | US$3.95m |
| Total liabilities | US$839.17k |
| Total assets | US$4.79m |
Recent financial health updates
Recent updates
An Intrinsic Calculation For Enveric Biosciences, Inc. (NASDAQ:ENVB) Suggests It's 40% Undervalued
Jul 02
Enveric Biosciences to raise $8M in stock offering for corporate use
Jul 25Enveric Biosciences Goes Psychedelic With MagicMed Acquisition
May 31Enveric Biosciences announces $10M registered direct offering
Jan 12Financial Position Analysis
Short Term Liabilities: ENVB's short term assets ($4.3M) exceed its short term liabilities ($839.2K).
Long Term Liabilities: ENVB has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ENVB is debt free.
Reducing Debt: ENVB currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ENVB has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ENVB has less than a year of cash runway if free cash flow continues to reduce at historical rates of 30.9% each year